Zongertinib structure
|
Common Name | Zongertinib | ||
|---|---|---|---|---|
| CAS Number | 2728667-27-2 | Molecular Weight | 535.60 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H29N9O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ZongertinibZongertinib is a potent tyrosine kinase inhibitor. Zongertinib can be used as an antineoplastic agent. Zongertinib also has been tested as pHER2 and EGFR inhibitor inhibiting a wide variety of cancers[1][2]. |
| Name | Zongertinib |
|---|
| Description | Zongertinib is a potent tyrosine kinase inhibitor. Zongertinib can be used as an antineoplastic agent. Zongertinib also has been tested as pHER2 and EGFR inhibitor inhibiting a wide variety of cancers[1][2]. |
|---|---|
| Related Catalog | |
| References |
[1]. WHO Drug Informat ion - World Health Organization (WHO). |
| Molecular Formula | C29H29N9O2 |
|---|---|
| Molecular Weight | 535.60 |
| InChIKey | YSGNGFPNTLERCR-UHFFFAOYSA-N |
| SMILES | C=CC(=O)NC1CCN(c2ncc3ncnc(Nc4ccc(Oc5ccc6c(c5)ncn6C)c(C)c4)c3n2)CC1 |